Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada

Abstract Background As research on HIV vaccines continues to advance, studies exploring the feasibility of this intervention are necessary to inform uptake and dissemination strategies with key populations, including people who use drugs (PWUD). Methods We conducted 25 in-depth qualitative interview...

Full description

Bibliographic Details
Main Authors: Taylor Fleming, Jenna Valleriani, Cara Ng, Lisa Maher, Will Small, Ryan McNeil
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Public Health
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12889-020-09202-6
_version_ 1819015961073680384
author Taylor Fleming
Jenna Valleriani
Cara Ng
Lisa Maher
Will Small
Ryan McNeil
author_facet Taylor Fleming
Jenna Valleriani
Cara Ng
Lisa Maher
Will Small
Ryan McNeil
author_sort Taylor Fleming
collection DOAJ
description Abstract Background As research on HIV vaccines continues to advance, studies exploring the feasibility of this intervention are necessary to inform uptake and dissemination strategies with key populations, including people who use drugs (PWUD). Methods We conducted 25 in-depth qualitative interviews examining HIV vaccine acceptability among PWUD in Vancouver, Canada. Participants were recruited from an ongoing prospective cohort of HIV-negative PWUD. Data were coded using NVivo, and analyzed thematically. Results Acceptability was framed by practical considerations such as cost and side effects, and was influenced by broader trust of government bodies and health care professionals. While an HIV vaccine was perceived as an important prevention tool, willingness to be vaccinated was low. Results suggest that future vaccine implementation must consider how to minimize the burden an HIV vaccine may place on PWUD. Centering the role of health care providers in information dissemination and delivery may assist with uptake. Conclusions Our findings suggest improvements in care and improved patient-provider relationships would increase the acceptability of a potential HIV vaccine among this population.
first_indexed 2024-12-21T02:40:03Z
format Article
id doaj.art-1bf5730b9cb641f69e424047fdff22e9
institution Directory Open Access Journal
issn 1471-2458
language English
last_indexed 2024-12-21T02:40:03Z
publishDate 2020-07-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj.art-1bf5730b9cb641f69e424047fdff22e92022-12-21T19:18:42ZengBMCBMC Public Health1471-24582020-07-012011910.1186/s12889-020-09202-6Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, CanadaTaylor Fleming0Jenna Valleriani1Cara Ng2Lisa Maher3Will Small4Ryan McNeil5British Columbia Centre on Substance UseBritish Columbia Centre on Substance UseBritish Columbia Centre on Substance UseThe Kirby Institute for Infection and Immunity, Faculty of Medicine, University of New South WalesBritish Columbia Centre on Substance UseBritish Columbia Centre on Substance UseAbstract Background As research on HIV vaccines continues to advance, studies exploring the feasibility of this intervention are necessary to inform uptake and dissemination strategies with key populations, including people who use drugs (PWUD). Methods We conducted 25 in-depth qualitative interviews examining HIV vaccine acceptability among PWUD in Vancouver, Canada. Participants were recruited from an ongoing prospective cohort of HIV-negative PWUD. Data were coded using NVivo, and analyzed thematically. Results Acceptability was framed by practical considerations such as cost and side effects, and was influenced by broader trust of government bodies and health care professionals. While an HIV vaccine was perceived as an important prevention tool, willingness to be vaccinated was low. Results suggest that future vaccine implementation must consider how to minimize the burden an HIV vaccine may place on PWUD. Centering the role of health care providers in information dissemination and delivery may assist with uptake. Conclusions Our findings suggest improvements in care and improved patient-provider relationships would increase the acceptability of a potential HIV vaccine among this population.http://link.springer.com/article/10.1186/s12889-020-09202-6VaccinesHIV/AIDSHIV preventionQualitative research
spellingShingle Taylor Fleming
Jenna Valleriani
Cara Ng
Lisa Maher
Will Small
Ryan McNeil
Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
BMC Public Health
Vaccines
HIV/AIDS
HIV prevention
Qualitative research
title Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
title_full Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
title_fullStr Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
title_full_unstemmed Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
title_short Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
title_sort acceptability of a hypothetical preventative hiv vaccine among people who use drugs in vancouver canada
topic Vaccines
HIV/AIDS
HIV prevention
Qualitative research
url http://link.springer.com/article/10.1186/s12889-020-09202-6
work_keys_str_mv AT taylorfleming acceptabilityofahypotheticalpreventativehivvaccineamongpeoplewhousedrugsinvancouvercanada
AT jennavalleriani acceptabilityofahypotheticalpreventativehivvaccineamongpeoplewhousedrugsinvancouvercanada
AT carang acceptabilityofahypotheticalpreventativehivvaccineamongpeoplewhousedrugsinvancouvercanada
AT lisamaher acceptabilityofahypotheticalpreventativehivvaccineamongpeoplewhousedrugsinvancouvercanada
AT willsmall acceptabilityofahypotheticalpreventativehivvaccineamongpeoplewhousedrugsinvancouvercanada
AT ryanmcneil acceptabilityofahypotheticalpreventativehivvaccineamongpeoplewhousedrugsinvancouvercanada